“Danielle Piomelli of UC Irvine and Olivier Manzoni of INSERM, the French national research agency, treated mice exhibiting symptoms of Fragile-X Syndrome, a disorder that causes autistic symptoms, with novel compounds that correct the signaling of endocannibinoid transmitters in the brain [which cannabinoids can do]. The mice showed dramatic behavioral improvements in maze tests measuring anxiety and open-space acceptance.”
Posted on: Sat, 15 Mar 2014 03:11:17 +0000